RP

Rituben Parmar

Active Director Director DIN 10189301
DIN 10189301 First appointment Jun 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rituben Parmar

Data last updated:

Rituben Parmar is a Director at Prolimb Ayurveda Private Limited (since 2023).

DIN 10189301
Primary Designation Director
First Appointment 02 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prolimb Ayurveda Private Limited U47190GJ2023PTC141813
Director02 Jun 20232023Active

Board colleagues of Rituben Parmar

NameDINCompanyDesignation
Jigarsinh Bhureshsinh Vaghela10189302Prolimb Ayurveda Private LimitedDirector

Directorship timeline

Open interactive timeline →
Prolimb Ayurveda Private Limited
Premium access

Shareholding and investment profile for Rituben Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rituben Parmar

Rituben Parmar currently holds 1 directorship: Prolimb Ayurveda Private Limited (Director, since 02 Jun 2023).

Rituben Parmar was first appointed on 02 Jun 2023 as Director at Prolimb Ayurveda Private Limited.

The current boards of Rituben Parmar's companies include Jigarsinh Bhureshsinh Vaghela (Prolimb Ayurveda Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available